文献速递术前评估与围术期医学疼痛医学区域麻醉与超声

美国Medicare受益人下肢截肢前后处方镇痛药使用的种族与民族差异

Racial and Ethnic Underserved Populations Prescription Analgesic Use Before and After Lower Extremity Amputation in US Medicare.
PubMed 文献 · Anesth Analg · 2025-01-01

该回顾性队列研究基于2011-2015年5%全国Medicare样本和2016-2018年15%按服务收费Medicare样本,纳入16068例接受非创伤性下肢截肢的受益人,探讨不同种族和民族群体与截肢前后处方阿片类及其他镇痛药使用的关联。结果显示,西班牙裔和其他种族受益人在截肢前6个月和截肢后6个月使用处方阿片类药物的 odds 均显著低于白人受益人。

要点

  • 西班牙裔截肢前6个月阿片类药物使用aOR为0.71(95%CI 0.65-0.78),低于白人。
  • 西班牙裔截肢后6个月阿片类药物使用aOR为0.78(95%CI 0.71-0.84),低于白人。
  • 其他种族截肢前后阿片类药物使用aOR分别为0.60和0.63,均低于白人。

核心结论

  • 在按服务收费的Medicare受益人中,西班牙裔和其他种族(如亚裔)受益人在非创伤性下肢截肢前后使用处方阿片类药物的 odds 低于白人受益人。
  • 需要努力确定潜在原因以确保公平的医疗保健可及性。

研究设计与样本

  • 回顾性队列研究,纳入2011-2015年5%全国Medicare受益人样本和2016-2018年15%按服务收费Medicare受益人样本。
  • 共纳入16068例接受非创伤性下肢截肢(大截肢和小截肢)的合格受益人,平均年龄65.1±12.7岁,女性占36.1%。
  • 暴露为Medicare理赔数据中的种族和民族分组(黑人、西班牙裔、美洲原住民、白人和其他,其他为亚裔及其他类别的组合)。
  • 使用多变量广义估计方程(logistic链接)分别估计截肢前6个月和截肢后6个月内处方阿片类药物使用的 odds,并调整社会人口学和健康状况因素(如Elixhauser指数)。

主要发现

  • 16068例受益人中有10107例(62.9%)为白人,3462例(21.5%)为黑人,1959例(12.2%)为西班牙裔,247例(1.5%)为美洲原住民,151例(2.9%)为其他种族受益人。
  • 截肢前6个月,西班牙裔受益人(aOR 0.71,95%CI 0.65-0.78)和其他种族受益人(aOR 0.60,95%CI 0.47-0.76)使用处方阿片类药物的 odds 显著低于白人受益人。
  • 截肢后6个月,西班牙裔受益人(aOR 0.78,95%CI 0.71-0.84)和其他种族受益人(aOR 0.63,95%CI 0.51-0.78)使用阿片类药物的 odds 低于白人受益人。

临床怎么用

  • 临床麻醉与围术期团队应关注下肢截肢患者中西班牙裔和其他种族群体在截肢前后阿片类药物处方可能偏低的现象。
  • 需进一步探究处方差异的潜在原因,以促进公平的疼痛管理和医疗保健可及性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Racial disparities exist in access to health care and management of multiple health conditions including chronic pain; however, racial disparities in pre- and postoperative pain management in lower extremity amputation are not well-studied. Our objective was to examine the association between different racial and ethnic groups and prescription opioid and other analgesics use before and after lower extremity amputation. We hypothesize prescription opioid and other analgesic use among Black, Hispanic, and Native American US Medicare beneficiaries undergoing lower extremity amputations will be lower compared to White US Medicare beneficiaries. METHODS: This retrospective cohort study included a 5% national sample of all Medicare beneficiaries from 2011 to 2015 and 15% national sample of fee-for-service Medicare beneficiaries from 2016 to 2018 undergoing nontraumatic, lower extremity amputations. The exposure of interest was racial and ethnic group membership (ie, Black, Hispanic, Native American, White, and others-with others being the combination of the categories Asian and other) as provided in Medicare claims data. Using multivariable generalized estimating equations with a logistic link to account for repeated measurements over time, we estimated the odds of prescription opioid use within 6 months before and after lower extremity amputation across different racial and ethnic groups separately, adjusting for sociodemographic and health status factors (eg, Elixhauser index). Adjusted odds ratios (aORs) and 95% confidence intervals (95% CI) were reported. RESULTS: Among 16,068 eligible beneficiaries who underwent major and minor amputations (mean age = 65.1 ± 12.7 years; female = 36.1%), 10,107 (62.9%) were White, 3462 (21.5%) were Black, 1959 (12.2%) were Hispanic, 247 (1.5%) were Native American, and 151 (2.9%) were beneficiaries of other races. During the 6 months before lower extremity amputation, Hispanic beneficiaries (aOR, 0.71, 95% CI, 0.65-0.78) and beneficiaries of other races (aOR, 0.60, 95% CI, 0.47-0.76) had significantly lower odds of using prescription opioids compared to White beneficiaries. Similarly, Hispanic beneficiaries (aOR, 0.78, 95% CI, 0.71-0.84) and beneficiaries of other races (aOR, 0.63, 95% CI, 0.51-0.78) were associated with lower odds of opioid use in the 6 months after amputation compared to White beneficiaries. CONCLUSIONS: Among fee-for-service Medicare beneficiaries, Hispanic and other (eg, Asian) fee-for-service Medicare beneficiaries had lower odds of prescription opioid use than their White counterparts before and after nontraumatic, lower extremity amputations. Efforts to determine the underlying reasons are needed to ensure equitable health care access.

来源:Anesth Analg,查看原文。版权归原作者所有。

引用

  1. Yang S, Wilson DL, Zhou L, et al. Racial and Ethnic Underserved Populations Prescription Analgesic Use Before and After Lower Extremity Amputation in US Medicare. Anesth Analg. 2025. PMID: 39051922. doi:10.1213/ANE.0000000000007160

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。